Selected Papers from the 4th International Conference on Inflammation and Infection Imaging
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 29
Special Issue Editors
Interests: nuclear medicine; infection imaging; inflammation imaging; thyroid cancer imaging; pre-clinical imaging; imaging immuno-therapy; imaging autoimmune diseases
Special Issues, Collections and Topics in MDPI journals
Interests: inflammation imaging; tumor micro-environment; personalized medicine
Interests: radiochemistry; nanotechnologies; nanoparticles; bacteria imaging
Special Issue Information
Dear Colleagues,
Following a tradition started in 1993, the 4th edition of the International Congress on "Imaging infections and inflammation" has been organized in Roma (Italy) from 5 to 7 December, 2024.
Scientific sessions included cardiovascular infections, bone infections, sterile inflammatory diseases, tumor microenvironments, and radiolabeled probes for imaging bacteria and fungi.
Each session included several lectures and roundtable discussions with the participation of several scientists and clinicians, experts in the field.
The best three oral presentations were given awards.
Since the high clinical relevance of such congress and the number and quality of studies presented, we decided to launch a Special Issue of the Journal of Clinical Medicine that could include all abstracts of congress presentations and a few selected full papers, accepted after peer review.
The early diagnosis of occult infections is a very important issue in medicine, especially for infections that do not present with obvious clinical signs but can have serious consequences if not treated promptly. The use of imaging techniques to detect hidden infections is becoming increasingly important due to their ability to visualize areas of the body that are difficult to explore, often before serious symptoms develop.
In addition to computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, nuclear medicine techniques have improved enormously in the last decade thanks to the availability of several new radiopharmaceuticals for single-photon emission computed tomography (SPECT) and positron emission tomography (PET) use.
Rapid identification of occult infections will allow starting targeted and personalized treatment, reducing the risk of complications.
Furthermore, early diagnosis of infection in the early stages will contribute to reducing the costs of patients’ treatment with better prognoses, especially in immunocompromised patients or those with comorbidities.
One of the major challenges is the differential diagnosis between sterile inflammation and septic infection. Despite the use of radiolabeled autologous white blood cells that can allow us to differentiate inflammation from infection, the gold standard technique would be to directly image and quantify the presence of bacteria or fungi.
Another important field of application of nuclear medicine techniques is the study of tumor microenvironments. Here, by using radiopharmaceuticals that specifically target fibroblasts, lymphocytes, endothelial, or mesenchymal cells, the aim is to establish a non-invasive tool for prognostic purposes and for selecting tailored treatment.
Both fields have an enormous clinical and economic impact and will drive nuclear medicine research for the next decades.
Prof. Dr. Alberto Signore
Dr. Chiara Lauri
Dr. Michela Varani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infection imaging
- inflammation imaging
- imaging tumor micro-environment
- bacteria imaging
- new radiopharmaceuticals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.